136 related articles for article (PubMed ID: 22396767)
1. The contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatments.
Lever M; George PM; Atkinson W; Elmslie JL; Slow S; Molyneux SL; Troughton RW; Richards AM; Frampton CM; Chambers ST
PLoS One; 2012; 7(3):e32460. PubMed ID: 22396767
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipids and betaine are related in an acute coronary syndrome cohort.
Lever M; George PM; Atkinson W; Molyneux SL; Elmslie JL; Slow S; Richards AM; Chambers ST
PLoS One; 2011; 6(7):e21666. PubMed ID: 21747945
[TBL] [Abstract][Full Text] [Related]
3. Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine.
Lever M; George PM; Slow S; Elmslie JL; Scott RS; Richards AM; Fink JN; Chambers ST
Cardiovasc Drugs Ther; 2009 Oct; 23(5):395-401. PubMed ID: 19653086
[TBL] [Abstract][Full Text] [Related]
4. Betaine excretion correlates with plasma homocysteine when plasma lipids are elevated.
Lever M; Slow S; George PM; Chambers ST
Clin Biochem; 2012 Jan; 45(1-2):154-6. PubMed ID: 22093969
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic.
Lever M; Atkinson W; George PM; Chambers ST
Clin Biochem; 2007 Nov; 40(16-17):1225-31. PubMed ID: 17706956
[TBL] [Abstract][Full Text] [Related]
6. Betaine and secondary events in an acute coronary syndrome cohort.
Lever M; George PM; Elmslie JL; Atkinson W; Slow S; Molyneux SL; Troughton RW; Richards AM; Frampton CM; Chambers ST
PLoS One; 2012; 7(5):e37883. PubMed ID: 22649561
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic.
Lever M; George PM; Dellow WJ; Scott RS; Chambers ST
Metabolism; 2005 Jan; 54(1):1-14. PubMed ID: 15562374
[TBL] [Abstract][Full Text] [Related]
8. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.
Olthof MR; van Vliet T; Verhoef P; Zock PL; Katan MB
PLoS Med; 2005 May; 2(5):e135. PubMed ID: 15916468
[TBL] [Abstract][Full Text] [Related]
9. Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects.
Atkinson W; Downer P; Lever M; Chambers ST; George PM
Eur J Nutr; 2007 Dec; 46(8):446-52. PubMed ID: 18060588
[TBL] [Abstract][Full Text] [Related]
10. Betaine: a key modulator of one-carbon metabolism and homocysteine status.
Ueland PM; Holm PI; Hustad S
Clin Chem Lab Med; 2005; 43(10):1069-75. PubMed ID: 16197300
[TBL] [Abstract][Full Text] [Related]
11. Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study.
Lever M; Slow S; McGregor DO; Dellow WJ; George PM; Chambers ST
Cardiovasc Diabetol; 2012 Jul; 11():34. PubMed ID: 22510294
[TBL] [Abstract][Full Text] [Related]
12. Dietary and supplementary betaine: effects on betaine and homocysteine concentrations in males.
Atkinson W; Slow S; Elmslie J; Lever M; Chambers ST; George PM
Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):767-73. PubMed ID: 19346114
[TBL] [Abstract][Full Text] [Related]
13. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation.
Holm PI; Bleie Ø; Ueland PM; Lien EA; Refsum H; Nordrehaug JE; Nygård O
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):301-7. PubMed ID: 14699020
[TBL] [Abstract][Full Text] [Related]
14. Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.
Lever M; McEntyre CJ; George PM; Slow S; Elmslie JL; Lunt H; Chambers ST; Parry-Strong A; Krebs JD
Cardiovasc Drugs Ther; 2014 Oct; 28(5):459-68. PubMed ID: 25060556
[TBL] [Abstract][Full Text] [Related]
15. Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects.
Xiao Y; Zhang Y; Lv X; Su D; Li D; Xia M; Qiu J; Ling W; Ma J
Lipids Health Dis; 2011 Aug; 10():137. PubMed ID: 21838883
[TBL] [Abstract][Full Text] [Related]
16. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
Soysal D; Savaş S; Susam I; Cevik C; Göldeli E; Sözmen E; Güneri S
Anadolu Kardiyol Derg; 2003 Mar; 3(1):26-34, AXVIII-AXIX. PubMed ID: 12626307
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of nicotinic acid and nicotinamide degradation on plasma betaine and choline levels.
Sun WP; Zhai MZ; Li D; Zhou Y; Chen NN; Guo M; Zhou SS
Clin Nutr; 2017 Aug; 36(4):1136-1142. PubMed ID: 27567458
[TBL] [Abstract][Full Text] [Related]
18. Elevated glycine betaine excretion in diabetes mellitus patients is associated with proximal tubular dysfunction and hyperglycemia.
Dellow WJ; Chambers ST; Lever M; Lunt H; Robson RA
Diabetes Res Clin Pract; 1999 Feb; 43(2):91-9. PubMed ID: 10221661
[TBL] [Abstract][Full Text] [Related]
19. [Hyperhomocysteinemia. A risk factor for the development of vascular diseases not associated with lipid levels].
Hyánek H; Stríbrný J; Sebesta P; Niederle P; Kramár J; Kozich V; Orendác O; Zayková K; Mandysová E; Borůvka V; Dvoráková J; Táborský L; Loucka M; Dubská L; Martiníková V; Machácková L; Cabrnochová I
Cas Lek Cesk; 1997 Dec; 136(23):720-3. PubMed ID: 9476374
[TBL] [Abstract][Full Text] [Related]
20. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
